HAP Trading’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-7,500
Closed -$229K 1911
2020
Q1
$229K Buy
+7,500
New +$794K 0.02% 516
2017
Q2
Sell
-81,100
Closed -$220K 1239
2017
Q1
$220K Sell
81,100
-1,900
-2% -$233K 0.01% 463
2016
Q4
$976K Buy
83,000
+72,900
+722% +$8.77M 0.05% 255
2016
Q3
$21K Sell
10,100
-22,600
-69% -$2.16M ﹤0.01% 859
2016
Q2
$37K Buy
+32,700
New +$2.75M ﹤0.01% 644

Other funds holding GWPH

HAP Trading's GWPH Position: Q2 2017 in Review

HAP Trading sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 13,900 shares — an estimated $1.68M sold.

HAP Trading first reported a position in GWPH in Q4 2016 and held it in 2 quarters. The position peaked at $2.39M in Q4 2016. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • HAP Trading reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
  • HAP Trading sold 13,900 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $1.68M.
  • HAP Trading first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 2 quarters.
  • HAP Trading's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.39M in Q4 2016.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.